|
Volumn 36, Issue 4, 2001, Pages 40-44
|
Management of pyoderma gangrenosum
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA INTERFERON;
ANABOLIC AGENT;
AZATHIOPRINE;
BENZOYL PEROXIDE;
CARBAMAZEPINE;
CHLORAMBUCIL;
CLOFAZIMINE;
COLCHICINE;
CORTICOSTEROID;
CROMOGLYCATE DISODIUM;
CYCLOPHOSPHAMIDE;
CYCLOSPORIN A;
DAPSONE;
DILTIAZEM;
ERYTHROMYCIN;
GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;
HUMAN IMMUNOGLOBULIN;
IMMUNOSUPPRESSIVE AGENT;
KETOCONAZOLE;
MESALAZINE;
METHYLPREDNISOLONE;
PHENOBARBITAL;
PHENYTOIN;
PREDNISONE;
RIFAMPICIN;
SALAZOSULFAPYRIDINE;
TACROLIMUS;
THALIDOMIDE;
TRIAMCINOLONE HEXACETONIDE;
UNINDEXED DRUG;
AGRANULOCYTOSIS;
ARTICLE;
DIABETES MELLITUS;
DIFFERENTIAL DIAGNOSIS;
DRUG PULSE THERAPY;
DRY SKIN;
HEMOLYSIS;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
LEG ULCER;
LEUKOPENIA;
METHEMOGLOBINEMIA;
NEPHROTOXICITY;
NEUROTOXICITY;
NEUTROPHIL CHEMOTAXIS;
POLYCYTHEMIA VERA;
PUSTULE;
PYODERMA GANGRENOSUM;
SKIN GRAFT;
SKIN PIGMENTATION;
TELANGIECTASIA;
TERATOGENICITY;
|
EID: 0035871343
PISSN: 87502836
EISSN: None
Source Type: Journal
DOI: 10.1080/21548331.2001.11444104 Document Type: Article |
Times cited : (10)
|
References (7)
|